State Street’s CalciMedica CALC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.22K Buy
+17,073
New +$34.6K ﹤0.01% 4254
2023
Q1
Sell
-2,505
Closed -$17.5K 4792
2022
Q4
$17.5K Hold
2,505
﹤0.01% 4757
2022
Q3
$33K Hold
2,505
﹤0.01% 4744
2022
Q2
$38K Hold
2,505
﹤0.01% 4778
2022
Q1
$43K Hold
2,505
﹤0.01% 4818
2021
Q4
$64K Buy
2,505
+1,037
+71% +$40.3K ﹤0.01% 4661
2021
Q3
$68K Sell
1,468
-1,473
-50% -$82.8K ﹤0.01% 4613
2021
Q2
$224K Sell
2,941
-4,782
-62% -$314K ﹤0.01% 4172
2021
Q1
$600K Buy
7,723
+1,907
+33% +$571K ﹤0.01% 3710
2020
Q4
$2.36M Buy
+5,816
New +$1.72M ﹤0.01% 3297

Other funds holding CALC

State Street's CALC Position: Q1 2026 in Review

State Street opened a new position in CalciMedica (CALC) in Q1 2026: 17,073 shares worth $9.22K. The stake represents ﹤0.01% of the portfolio and ranks #4254 among its holdings. This is a return to the name: State Street previously reported a position in CALC as recently as Q4 2022.

State Street first reported a position in CALC in Q4 2020 and has held it in 10 quarters since. The position peaked at $2.36M in Q4 2020. 27 funds tracked by Wall St. Rank hold CALC as of Q1 2026.

  • State Street held 17,073 shares of CalciMedica worth $9.22K as of Q1 2026.
  • CalciMedica was a new State Street position in Q1 2026.
  • CalciMedica made up ﹤0.01% of State Street's portfolio in Q1 2026, its #4254 holding.
  • State Street first reported a position in CalciMedica in Q4 2020 and has held it in 10 quarters since.
  • State Street's CalciMedica position peaked at $2.36M in Q4 2020.
  • 27 funds tracked by Wall St. Rank held CalciMedica as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.